NDC 70518-1472

Calcium Polycarbophil 625 mg

Calcium Polycarbophil 625 Mg

Calcium Polycarbophil 625 mg is a Oral Tablet in the Human Otc Drug category. It is labeled and distributed by Remedyrepack Inc.. The primary component is Calcium Polycarbophil.

Product ID70518-1472_78738cab-13c4-65d2-e053-2a91aa0ae927
NDC70518-1472
Product TypeHuman Otc Drug
Proprietary NameCalcium Polycarbophil 625 mg
Generic NameCalcium Polycarbophil 625 Mg
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date2018-10-05
Marketing CategoryOTC MONOGRAPH NOT FINAL / OTC MONOGRAPH NOT FINAL
Application Numberpart334
Labeler NameREMEDYREPACK INC.
Substance NameCALCIUM POLYCARBOPHIL
Active Ingredient Strength625 mg/1
NDC Exclude FlagN
Listing Certified Through2019-12-31

Packaging

NDC 70518-1472-0

30 TABLET in 1 BLISTER PACK (70518-1472-0)
Marketing Start Date2018-10-05
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 70518-1472-0 [70518147200]

Calcium Polycarbophil 625 mg TABLET
Marketing CategoryOTC monograph not final
Application Numberpart334
Product TypeHUMAN OTC DRUG
Marketing Start Date2018-10-05
Marketing End Date2020-05-27

Drug Details

Active Ingredients

IngredientStrength
CALCIUM POLYCARBOPHIL625 mg/1

OpenFDA Data

SPL SET ID:d7729b4b-9cdb-4342-9d89-24e5f8f10fa9
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 308934
  • NDC Crossover Matching brand name "Calcium Polycarbophil 625 mg" or generic name "Calcium Polycarbophil 625 Mg"

    NDCBrand NameGeneric Name
    69618-030Calcium Polycarbophil 625 mgCalcium Polycarbophil 625 mg
    70518-1472Calcium Polycarbophil 625 mgCalcium Polycarbophil 625 mg

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.